NCT02254993View on ClinicalTrials.gov

Phase 2, Open-Label Study for Safety, Microbiology and PK of Single or Multiple Oral C16G2 Gel Doses

PHASE2CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

July 31, 2015

Conditions
Dental Caries
Interventions
DRUG

C16G2

antimicrobial peptide

Trial Locations (2)

59901

Plaza West II Dental Group, Kalispell

84124

Jean Brown Research, Salt Lake City

Sponsors
All Listed Sponsors
lead

Armata Pharmaceuticals, Inc.

INDUSTRY

NCT02254993 - Phase 2, Open-Label Study for Safety, Microbiology and PK of Single or Multiple Oral C16G2 Gel Doses | Biotech Hunter | Biotech Hunter